Jan 15, 2026
What are clinical management algorithms (imaging thresholds and symptom criteria) for pausing or restarting anti‑amyloid therapy after ARIA is detected?
Clinical algorithms to pause or restart anti‑amyloid monoclonal antibody therapy after amyloid‑related imaging abnormalities (ARIA) hinge on two parallel axes: radiologic severity on standardized MRI ...